• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    BeOne Medicines Ltd. - American Depositary Shares (NQ:ONC)

    313.35 -2.66 (-0.84%)
    Streaming Delayed Price Updated: 10:05 AM EDT, Aug 3, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 42,135
    Open 316.01
    Bid (Size) 312.77 (80)
    Ask (Size) 313.96 (40)
    Prev. Close 316.01
    Today's Range 311.36 - 316.01
    52wk Range 253.95 - 385.22
    Shares Outstanding 1,211,067,023
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    BeOne Medicines Expands U.S. Manufacturing with Total Investment of More Than $1 Billion to Advance Innovative Cancer Medicines
    From BeOne Medicines Ltd.
    Via Business Wire
    News headline image
    A BeOne Founder Sold $34.6 Million in Stock but Keeps a Massive Position ↗
    Executed under pre-established trading plan, this sale reduces the chief executive's direct holdings by just 2%. 
    Via The Motley Fool
    Topics Regulatory Compliance

    Performance

    YTD
    +0.7%
    +0.7%
    1 Month
    +1.3%
    +1.3%
    3 Month
    +5.5%
    +5.5%
    6 Month
    -9.2%
    -9.2%
    1 Year
    +3.0%
    +3.0%

    More News

    Read More
    News headline image
    BeOne Medicines to Announce Second Quarter 2026 Financial Results on August 5
    From BeOne Medicines Ltd.
    Via Business Wire
    BEONE MEDICINES LTD-ADR (NASDAQ:ONC) Passes Minervini's SEPA Screen with Strong Technicals and High Growth Momentum ↗
    Via Chartmill
    News headline image
    BeOne Medicines Announces Positive Phase 3 Results for BRUKINSA in Frontline Mantle Cell Lymphoma
    From BeOne Medicines Ltd.
    Via Business Wire
    News headline image
    BeOne Medicines’ Foundational Hematology Franchise Leads Next Era of B-Cell Cancer Innovation at EHA 2026
    From BeOne Medicines Ltd.
    Via Business Wire
    News headline image
    BeOne Showcases Landmark Phase 3 Data in CLL Patients Aged 80+ at EHA 2026, Reinforcing BRUKINSA Benefit
    From BeOne Medicines Ltd.
    Via Business Wire
    News headline image
    BeOne Medicines Signals Solid Tumor Breakout as Three Programs Near Phase 3 ↗
    Via MarketBeat
    News headline image
    BeOne Medicines Highlights Accelerating Solid Tumor Pipeline with New Data at ASCO 2026
    From BeOne Medicines Ltd.
    Via Business Wire
    News headline image
    BeOne Medicines Establishes Standard for Long-Term Disease Control in CLL with BRUKINSA 78-Month Data at ASCO 2026
    From BeOne Medicines Ltd.
    Via Business Wire
    News headline image
    BeOne Medicines Announces Phase 3 HERIZON-GEA Data Published in NEJM and Presented at ASCO 2026
    From BeOne Medicines Ltd.
    Via Business Wire
    News headline image
    BeOne Medicines to Present at the Goldman Sachs 47th Annual Global Healthcare Conference
    From BeOne Medicines Ltd.
    Via Business Wire
    News headline image
    BeOne Medicines Sets the Pace in Oncology at ASCO and EHA 2026 with 60+ Abstracts
    From BeOne Medicines Ltd.
    Via Business Wire
    News headline image
    BeOne Medicines Launches One Save Changes Everything, a Global Cancer Care Awareness Campaign with Soccer Legend Tim Howard
    From BeOne Medicines Ltd.
    Via Business Wire
    News headline image
    Patient Square Makes a Big Bet on Nektar Pharmaceuticals (NKTR) Purchasing 210,000 Shares ↗
    Via The Motley Fool
    News headline image
    What to Know About This Fund’s $50 Million Exit From Ascendis Pharma ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    This Fund Has a $75 Million Bet on a Hair Loss Biotech Stock Up More Than 500% Post-IPO ↗
    Via The Motley Fool
    Topics Initial Public Offering
    News headline image
    Why This Hedge Fund Added $29 Million to a Cancer Stock Already Up 700% ↗
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    BeOne Medicines’ BEQALZI™ (sonrotoclax) Approved by U.S. FDA as First and Only BCL2 Inhibitor for R/R Mantle Cell Lymphoma
    From BeOne Medicines Ltd.
    Via Business Wire
    News headline image
    BeOne Medicines Announces First Quarter 2026 Financial Results and Business Updates
    From BeOne Medicines Ltd
    Via Business Wire
    News headline image
    U.S. FDA Grants Priority Review to BeOne Medicines’ TEVIMBRA in First-Line HER2+ GEA
    From BeOne Medicines Ltd.
    Via Business Wire
    News headline image
    BeOne Medicines to Announce First Quarter 2026 Financial Results on May 6
    From BeOne Medicines Ltd.
    Via Business Wire
    News headline image
    This Fintech Stock Is Up 21% in a Year as Profits Surge, but One Fund's Nearly $300 Million Sale Cut Its Stake in Half ↗
    Via The Motley Fool
    News headline image
    BeOne Medicines Announces Fourth Quarter and Full Year 2025 Financial Results, Highlighting Global Success of BRUKINSA and Foundational Oncology Leadership
    From BeOne Medicines Ltd.
    Via Business Wire
    News headline image
    Investor Buys Up $81 Million in Praxis Stock as Shares Soar Over 300% in One Year ↗
    Via The Motley Fool
    Topics Regulatory Compliance

    Frequently Asked Questions

    Is BeOne Medicines Ltd. - American Depositary Shares publicly traded?
    Yes, BeOne Medicines Ltd. - American Depositary Shares is publicly traded.
    What exchange does BeOne Medicines Ltd. - American Depositary Shares trade on?
    BeOne Medicines Ltd. - American Depositary Shares trades on the Nasdaq Stock Market
    What is the ticker symbol for BeOne Medicines Ltd. - American Depositary Shares?
    The ticker symbol for BeOne Medicines Ltd. - American Depositary Shares is ONC on the Nasdaq Stock Market
    What is the current price of BeOne Medicines Ltd. - American Depositary Shares?
    The current price of BeOne Medicines Ltd. - American Depositary Shares is 313.35
    When was BeOne Medicines Ltd. - American Depositary Shares last traded?
    The last trade of BeOne Medicines Ltd. - American Depositary Shares was at 08/03/26 10:05 AM ET
    What is the market capitalization of BeOne Medicines Ltd. - American Depositary Shares?
    The market capitalization of BeOne Medicines Ltd. - American Depositary Shares is 379.49B
    How many shares of BeOne Medicines Ltd. - American Depositary Shares are outstanding?
    BeOne Medicines Ltd. - American Depositary Shares has 379B shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.